Nektar Therapeutics Overview
Nektar Therapeutics Target Price
Analysts' 12-month price predictions for NKTR.
Get informed when a big investor buys or sells
+ FollowShare Price
$59.23
Average Target Price
$144.00
143.1% upside
143.1% upside7 analysts in the last 4 months
High: $192 | Low: $80
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-11 | WedbushMartin Fan | $80 | 35.1% upside |  |
| 2026-05-08 | Piper SandlerYasmeen Rahimi | $192 | 224.2% upside | |
| 2026-04-21 | Wedbush | $95 | 60.4% upside | |
| 2026-04-20 | H.C. Wainwright | $185 | 212.3% upside | |
| 2026-03-13 | OppenheimerJay Olson | $140 | 136.4% upside | |
| 2026-02-10 | BTIG | $151 | 154.9% upside | |
| 2026-02-10 | H.C. Wainwright | $165 | 178.6% upside | |
| 2026-01-26 | Piper SandlerYasmeen Rahimi | $105 | 77.3% upside | |
| 2025-12-16 | H.C. Wainwright | $135 | 127.9% upside | |
| 2025-12-16 | OppenheimerJay Olson | $115 | 94.2% upside | |
| 2025-11-24 | JefferiesRoger Song | $121 | 104.3% upside | |
| 2025-09-18 | JefferiesRoger Song | $99 | 67.1% upside | |
| 2022-04-18 | Mizuho SecuritiesMara Goldstein | $6 |  89.9% downside | |
| 2022-03-01 | J.P. MorganJessica Fye | $17 | 71.3% downside | |
| 2021-11-08 | Ladenburg Thalmann & Co.Aydin Huseynov | $20 | 66.2% downside | |
| 2021-05-18 | Goldman SachsChris Shibutani | $24 | 59.5% downside | |